205 related articles for article (PubMed ID: 20413892)
1. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells.
Wang ZF; Yin J; Zhang Y; Zhu LQ; Tian Q; Wang XC; Li HL; Wang JZ
J Alzheimers Dis; 2010; 20(1):145-57. PubMed ID: 20164595
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.
Li HL; Wang HH; Liu SJ; Deng YQ; Zhang YJ; Tian Q; Wang XC; Chen XQ; Yang Y; Zhang JY; Wang Q; Xu H; Liao FF; Wang JZ
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3591-6. PubMed ID: 17360687
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
5. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
[TBL] [Abstract][Full Text] [Related]
6. Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation.
Shim SB; Lim HJ; Chae KR; Kim CK; Hwang DY; Jee SW; Lee SH; Sin JS; Leem YH; Lee SH; Cho JS; Lee HH; Choi SY; Kim YK
Neuroscience; 2007 May; 146(2):730-40. PubMed ID: 17337327
[TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
Avila J; Wandosell F; Hernández F
Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of tau by death-associated protein kinase 1 antagonizes the kinase-induced cell apoptosis.
Duan DX; Chai GS; Ni ZF; Hu Y; Luo Y; Cheng XS; Chen NN; Wang JZ; Liu GP
J Alzheimers Dis; 2013; 37(4):795-808. PubMed ID: 23948915
[TBL] [Abstract][Full Text] [Related]
9. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
10. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice.
Uno Y; Iwashita H; Tsukamoto T; Uchiyama N; Kawamoto T; Kori M; Nakanishi A
Brain Res; 2009 Nov; 1296():148-63. PubMed ID: 19698704
[TBL] [Abstract][Full Text] [Related]
13. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine.
McNeill-Blue C; Wetmore BA; Sanchez JF; Freed WJ; Merrick BA
Brain Res; 2006 Sep; 1112(1):1-15. PubMed ID: 16901471
[TBL] [Abstract][Full Text] [Related]
15. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model.
Zilkova M; Zilka N; Kovac A; Kovacech B; Skrabana R; Skrabanova M; Novak M
J Alzheimers Dis; 2011; 23(1):161-9. PubMed ID: 20966551
[TBL] [Abstract][Full Text] [Related]
17. Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells.
Mookherjee P; Johnson GV
Brain Res; 2001 Dec; 921(1-2):31-43. PubMed ID: 11720709
[TBL] [Abstract][Full Text] [Related]
18. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
Watcharasit P; Thiantanawat A; Satayavivad J
J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
[TBL] [Abstract][Full Text] [Related]
19. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
20. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
Wang JZ; Wang ZH
Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
